ATE466088T1 - Zufällige integration von polynukleotide nach in vivo linearisierung - Google Patents

Zufällige integration von polynukleotide nach in vivo linearisierung

Info

Publication number
ATE466088T1
ATE466088T1 AT02798716T AT02798716T ATE466088T1 AT E466088 T1 ATE466088 T1 AT E466088T1 AT 02798716 T AT02798716 T AT 02798716T AT 02798716 T AT02798716 T AT 02798716T AT E466088 T1 ATE466088 T1 AT E466088T1
Authority
AT
Austria
Prior art keywords
present
polynucleotides
random integration
vector
polynucleotide
Prior art date
Application number
AT02798716T
Other languages
English (en)
Inventor
Andre Choulika
Jean-Stephane Joly
Violette Thermes
Filomena Ristoratore
Original Assignee
Cellectis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectis filed Critical Cellectis
Application granted granted Critical
Publication of ATE466088T1 publication Critical patent/ATE466088T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/108Plasmid DNA episomal vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/80Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02798716T 2001-09-14 2002-09-12 Zufällige integration von polynukleotide nach in vivo linearisierung ATE466088T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31881801P 2001-09-14 2001-09-14
US33063901P 2001-10-26 2001-10-26
PCT/EP2002/010224 WO2003025183A2 (en) 2001-09-14 2002-09-12 Random integration of a polynucleotide after in vivo linearization

Publications (1)

Publication Number Publication Date
ATE466088T1 true ATE466088T1 (de) 2010-05-15

Family

ID=26981685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02798716T ATE466088T1 (de) 2001-09-14 2002-09-12 Zufällige integration von polynukleotide nach in vivo linearisierung

Country Status (9)

Country Link
US (1) US7098031B2 (de)
EP (1) EP1427828B1 (de)
JP (1) JP4436130B2 (de)
AT (1) ATE466088T1 (de)
AU (1) AU2002333832B2 (de)
DE (1) DE60236182D1 (de)
DK (1) DK1427828T3 (de)
ES (1) ES2342159T3 (de)
WO (1) WO2003025183A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7102055B1 (en) * 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
WO1999025821A1 (en) * 1997-11-18 1999-05-27 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
EP1151124A1 (de) * 1999-02-03 2001-11-07 The Children's Medical Center Corporation Genreparatur durch in vivo excision von targeting dna
AU2002350039A1 (en) 2001-10-29 2003-05-12 Renovis, Inc. Method for isolating cell-type specific mrnas
FR2879622B1 (fr) * 2004-12-17 2008-02-01 Agronomique Inst Nat Rech Procede in vitro de production d'ovocytes ou d'oeufs presentant une modification genomique ciblee
WO2006074956A1 (en) * 2005-01-14 2006-07-20 Bayer Bioscience N.V. Improved plant transformation methods
ES2390132T3 (es) * 2005-07-18 2012-11-06 Pioneer Hi-Bred International Inc. Sitios de recombinación FRT modificados y métodos de uso
US7663019B2 (en) 2006-05-24 2010-02-16 North Carolina State University Transgenic snakes and methods of making
PL2602323T3 (pl) 2007-06-01 2018-06-29 Open Monoclonal Technology, Inc. Kompozycje i sposoby hamowania endogennych genów immunoglobin i wytwarzania transgenicznych ludzkich przeciwciał typu idiotypowego
EP2167666A2 (de) 2007-06-29 2010-03-31 Pioneer Hi-Bred International Inc. Verfahren zur veränderung des genoms einer monokotyledonen-zelle
WO2009114321A2 (en) 2008-03-11 2009-09-17 Precision Biosciencs, Inc. Rationally-designed meganucleases for maize genome engineering
EP3369827B1 (de) 2008-03-12 2020-12-23 The Rockefeller University Verfahren und zusammensetzungen zur translationalen profilierung und molekularen phänotypisierung
CA2722797A1 (en) * 2008-04-28 2009-11-05 Precision Biosciences, Inc. Fusion molecules of rationally-designed dna-binding proteins and effector domains
CA2794037A1 (en) 2010-03-22 2011-09-29 Philip Morris Products S.A. Modifying enzyme activity in plants
AR085302A1 (es) 2011-02-24 2013-09-18 Sanofi Sa Metodo de produccion de anticuerpos sialilados
CA2865097A1 (en) * 2012-02-20 2013-08-29 Advanced Tactical Ordnance LLC Chimeric dna identifier
US9797004B2 (en) 2012-06-12 2017-10-24 Syngenta Participations Ag Methods and compositions for determination of vector backbone in a nucleic acid sample
WO2014083379A1 (en) 2012-11-30 2014-06-05 Institut Pasteur Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
ES2870983T3 (es) 2014-12-19 2021-10-28 Univ Nantes Anticuerpos anti-IL-34
USD765215S1 (en) 2015-01-22 2016-08-30 United Tactical Systems, Llc Non-lethal projectile
US9766049B2 (en) 2015-01-27 2017-09-19 United Tactical Systems, Llc Aerodynamic projectile
WO2017153432A1 (en) 2016-03-07 2017-09-14 Pierre Fabre Medicament A new universal method to capture and analyze adcs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
IL268049B2 (en) 2017-01-19 2025-08-01 Omniab Inc Transgenic rodent human antibodies with multiple immunoglobulin heavy chain loci
CN107372348A (zh) * 2017-08-31 2017-11-24 广西沙田仙人滩农业投资有限公司 一种绿壳蛋鸡育虫生态养殖方法
WO2019110662A1 (en) 2017-12-05 2019-06-13 Progastrine Et Cancers S.À R.L. Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
EP3759492A1 (de) 2018-02-27 2021-01-06 ECS-Progastrin SA Progastrin als biomarker für immuntherapie
CN112740043A (zh) 2018-07-20 2021-04-30 皮埃尔法布雷医药公司 Vista受体
US20210277421A1 (en) * 2018-08-06 2021-09-09 NemaMetrix, Inc Homologous Recombination Reporter Construct and Uses Thereof
MX2021003580A (es) 2018-09-28 2021-10-13 Pf Medicament Nuevas inmunocitocinas para el tratamiento contra el cancer.
US20220306736A1 (en) 2019-09-04 2022-09-29 Y-Biologics Inc. Anti-vsig4 antibody or antigen binding fragment and uses thereof
EP4073117A1 (de) 2019-12-10 2022-10-19 Institut Pasteur Neuer antikörper, der menschliche fcgriiia und fcgriiib blockiert
EP3889183A1 (de) 2020-04-01 2021-10-06 Pierre Fabre Medicament Proteinkomplex mit einem immunzytokin
US20240158503A1 (en) 2021-03-03 2024-05-16 Pierre Fabre Medicament Anti-vsig4 antibody or antigen binding fragment and uses thereof
US20240209094A1 (en) 2021-04-30 2024-06-27 Pierre Fabre Medicament New stable anti-vista antibody
CN119698431A (zh) 2022-05-02 2025-03-25 皮埃尔法布雷医药公司 新的抗vista抗体制剂
WO2024121380A1 (en) 2022-12-08 2024-06-13 Pierre Fabre Medicament Vaccinal composition and adjuvant
WO2024209089A1 (en) 2023-04-07 2024-10-10 Commissariat A L'energie Atomique Et Aux Energies Alternatives Use of antibody against the endothelin receptor b for diagnostic and therapeutic applications
WO2025262307A2 (en) 2024-06-21 2025-12-26 Institut Pasteur Vhh suitable to vectorize molecules intracellularly
WO2025262278A1 (en) 2024-06-21 2025-12-26 Institut Pasteur A neurovita short interfering peptide suitable for neuroprotection and neuroregeneration and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474896A (en) * 1992-05-05 1995-12-12 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US5792632A (en) * 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Also Published As

Publication number Publication date
WO2003025183A2 (en) 2003-03-27
WO2003025183A3 (en) 2003-08-28
ES2342159T3 (es) 2010-07-02
JP2005503161A (ja) 2005-02-03
JP4436130B2 (ja) 2010-03-24
DE60236182D1 (de) 2010-06-10
AU2002333832B9 (en) 2003-04-01
US7098031B2 (en) 2006-08-29
US20030106077A1 (en) 2003-06-05
DK1427828T3 (da) 2010-07-19
EP1427828B1 (de) 2010-04-28
EP1427828A2 (de) 2004-06-16
AU2002333832B2 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
ATE466088T1 (de) Zufällige integration von polynukleotide nach in vivo linearisierung
WO2019103442A3 (ko) CRISPR/Cpf1 시스템을 이용한 유전체 편집용 조성물 및 이의 용도
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
DE602005027621D1 (de) Verwendung einer Nukleinsäure zur Herstellung einer transgenen Pflanze mit verbesserter Toleranz gegenüber Trockenheit
ATE303435T1 (de) Alternansucrase-kodierende nukleinsäure moleküle
CY1107119T1 (el) Κλωνωση και εκφραση μιας ανθεκτικης εις τα οξεα εξωκυτταρικης λιπασης yarrowia lipolytica
DE69834908D1 (de) Verfahren zur erhöhung der expression von endogenen oder exogenen genprodukten in pflanzen
WO2004009761A3 (en) Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
EP2169069A3 (de) Stressbedingte Phosphataseproteine und Verfahren zu deren Verwendung für Pflanzen
BR0209745A (pt) Cromossomas artificiais de plantas, usos e dos mesmos e método para preparação de cromossomas artificiais de plantas
BR0009471A (pt) Composições e processos para modificação de transcrição de gene
ATE526818T1 (de) Gentechnisch hergestellte wasserlinse
ATE471378T1 (de) Dna-konstrukte und verfahren zur verbesserung der produktion kommerziell realisierbarer transgener pflanzen
EP2278018A3 (de) Nukleinsäuren die für Proteine kodieren, die an abiotischer Stressantwort beteiligt sind
NO20020949D0 (no) Fettsyredesaturasegen fra planter
WO2001081600A3 (en) Transgenic plants
MXPA02012475A (es) Captura de genes activados ires en plantas.
DE10346611A1 (de) Promotor zur epidermisspezifischen Transgenexpression in Pflanzen
AR047590A1 (es) Alteracion de la estructura de la raiz durante el desarrollo de la planta
DE69919186D1 (de) Transgene geminivirus-resistente pflanzen
WO2001064890A3 (en) Novel defense induced genes and uses thereof
WO2000065040A3 (en) Cell cycle genes from plants and methods of use
ATE318920T1 (de) Promotoren zur genexpression in karyopsen von pflanzen
ATE455863T1 (de) Methoden und zusammensetzungen zur identifikation von gen-funktion
WO2001059139A3 (de) Ozon- und/oder pathogen-induzierbare genexpression in pflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427828

Country of ref document: EP